LAE-102

• Description :

  LAE-102, a monoclonal antibody, is an activin receptor type II-A (ACTRIIA/ACVR2) antagonist. LAE-102 is promising for research of endocrine and metabolic diseases, tumors, and respiratory system diseases[1].

• UNSPSC :

  12352203

• Target :

  Anaplastic lymphoma kinase (ALK) ; TGF-beta/Smad; TGF-β Receptor

• Related Pathways :

  Protein Tyrosine Kinase/RTK; Stem Cell/Wnt; TGF-beta/Smad

• Applications :

  Metabolism-protein/nucleotide metabolism

• Field of Research :

  Cancer; Endocrinology; Metabolic Disease

• Purity :

  99.46

• Smiles :

  [LAE-102]

• Molecular Weight :

  (144.92 kDa)

• References & Citations :

  [1]https://synapse.zhihuiya.com/drug/900ddb627c6a4b1a88d3f4ef37e15c1c

• Shipping Conditions :

  Dry Ice

• Storage Conditions :

  Store at -80°C for 2 years

• Scientific Category :

  Inhibitory Antibodies

• Clinical Information :

  Phase 1